Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Equity: 2012-2025

Historic Return on Equity for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.55%.

  • CorMedix's Return on Equity rose 133.00% to 0.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55%, marking a year-over-year increase of 133.00%. This contributed to the annual value of -0.50% for FY2022, which is 2.00% up from last year.
  • CorMedix's Return on Equity amounted to 0.55% in Q3 2025, which was up 77.96% from 0.31% recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Return on Equity peaked at 0.55% during Q3 2025, and registered a low of -0.95% during Q2 2024.
  • Moreover, its 3-year median value for Return on Equity was -0.60% (2023), whereas its average is -0.35%.
  • Per our database at Business Quant, CorMedix's Return on Equity decreased by 24bps in 2024 and then spiked by 133bps in 2025.
  • Quarterly analysis of 5 years shows CorMedix's Return on Equity stood at -0.47% in 2021, then declined by 6bps to -0.52% in 2022, then declined by 12bps to -0.60% in 2023, then dropped by 18bps to -0.25% in 2024, then surged by 133bps to 0.55% in 2025.
  • Its last three reported values are 0.55% in Q3 2025, 0.31% for Q2 2025, and 0.17% during Q1 2025.